The Russian prospective controlled trial of bromexhine+spironolactone (n=103, 33 treated) is out with outstanding results:
"odds ratio of having a positive PCR or hospitalization for ≥10 days was 0.07 (95% CI: 0.008–0.61: p = 0.016) with bromhexine+spironolactone vs controls."
Conversation
The report in Russian only so far.
lib.ossn.ru/jour/article/v
And my Abstract translation for your convenience:
Replying to
The clinical features of the propensity-score matched patients.
36% of the control group got bromhexine.
1
10
From the study:
1
1
12
Importantly, the study was started as a randomized controlled trial but randomization was dropped as signs of efficacy became too strong for the hospital personnel to deny the chance of treatment to further patients.
2
7
44
The dosing was:
• bromhexine (8 mg x 4 times daily)
• spironolactone (25-50 mg/day)
for 10 days
2
8
37